InsidersTradesSigma
Follow the 바디텍메드 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바디텍메드 has logged 3 public disclosures. Market capitalisation: €243.8bn. The latest transaction was reported on 7 April 2026 (Purchase). Among the most active insiders: 최규리. Every trade is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€24,744
2 ops.
Buy Volume
n/a
1 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,673 of 29,062 companies
69.3
score / 100
Value63
Quality75
FCF yld-4.9%
Earn yld9.7%
EV/EBITDA6.8x
ROE11%
Gross mgn59%
Net mgn15%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Acerca de 바디텍메드
바디텍메드 es una empresa de salud y farmacéutica centrada en el desarrollo de dispositivos médicos y pruebas de diagnóstico. La empresa cotiza en el mercado XKRX.